We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Link Found Between Stem Cells and Tumors

By Biotechdaily staff writers
Posted on 13 Sep 2005
Researchers now have proof that certain kinds of cancer originates with stem cell defects. More...
A recent study demonstrates that if key molecules are not positioned in the proper locations within stem cells before they divide, the result can be deadly tumor formation.

Cells in the very early embryo are identical and undergo fast division. However, they soon begin differentiating into more specific types, eventually becoming specialized cells such as blood, neurons, or muscle. As they differentiate, they should stop dividing and usually become entrenched in specific tissues. Some tumor cells are more like stem cells because they are identical, they divide rapidly, and in the worst case--metastasis--they travel through the body and implant themselves in new tissues.

Specialized cells die by way of age or injuries, so the body keeps reserves of stem cells on hand to produce replacements. Typically, the stem cell divides into two types: one that is just like the parent, which is kept to maintain the stock, and another that differentiates. This is what occurs with neuroblasts. Cell division creates one large neuroblast and a smaller cell that can become part of a nerve. This process is controlled by events that occur before division. The parent cell becomes asymmetrical: it accumulates a set of special molecules, including Prospero and other proteins, in the region that will sprout off and become the specialized cell.

This research was performed by investigators from the European Molecular Biology Laboratory (EMBL, Heidelberg, Germany) and the Institute of Biomedical Research of the Parc Cientific de Barcelona (IRB-PCB; Spain). Their findings were published in the September 4, 2005, on-line edition of the journal Nature Genetics.

"This asymmetry provides the new cell with molecules it needs to launch new genetic programs that tell it what to become,” remarked Dr. Cayetano Gonzalez, whose team started the project at EMBL and has continued to study the process as they moved to the IRB-PCB. "The current study investigates what happens when the process of localizing these molecules is disturbed.”

Whether Prospero and its cohorts get to the proper place depends on the activity of specific genes in the stem cell. Emmanuel Caussinus, an EMBL Ph.D. student from Dr. González's group, created neuroblasts in which these genes were disrupted. "We no longer had normal neuroblasts and daughter cells capable of becoming part of a nerve,” Mr. Caussinus noted. "Instead, we had a tumor.”

When these modified cells were transplanted into flies, the results were quick and dramatic. The tissue containing the modified cells grew to 100 times its initial size, cells invaded other tissues, and death followed. The growing tumor became "immortal,” according to Mr. Caussinus. Cells could be re-transplanted into new hosts for years, generation after generation, with similar effects.

This study confirms that certain genes in stem cells--those which regulate the destinies of daughter cells--are vital. If such genes are disrupted, the new cells may no longer be able to control their reproduction, and this could lead to cancer. "It puts the focus on the events that create asymmetrical collections of molecules inside stem cells,” said Dr. González. "This suggests new lines of investigation into the relationship between stem cells and tumors in other model organisms and humans.”


Related Links:
European Molecular Biology Laboratory
Parc Cientific de Barcelona

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.